News

South London leaseholders have won a legal battle to prove they do not have to pay service charges for a concierge and other ...
Viridian Therapeutics Inc. (NASDAQ:VRDN) is one of the best low priced pharma stocks to buy now. Earlier on May 20, Viridian ...
Metro Performance Glass Ltd ( ($AU:MPP) ) has issued an announcement. The Commerce Commission has announced it will issue a Statement of Issues ...
Viridian is a high-end and nature-heavy community of 2,300 acres that includes 500 acres of open space, five lakes and miles ...
Dallas-based StreetLights Residential has broken ground on Phase III of Viridian, a multifamily project in Arlington that will add 410 units to the local supply. Apartments will feature studio, one- ...
The first of nearly four dozen new built-to-rent homes were unveiled in Arlington’s Viridian community on July 15, offering ...
The Commerce Commission has decided to issue a Statement of Issues relating to the application from Viridian NZ Bidco Limited seeking clearance to acquire up to 100% of the shares in Metro Performance ...
The final piece of a sprawling, nature-oriented community in Arlington is taking shape, promising to bring more upscale ...
Viridian specs it at 50K hours for a CR 2032 battery, which means that it can be left on all the time and forgotten. Since the RFX45 is an INSTANT-ON optic, it ...
The Commerce Commission has decided to issue a Statement of Issues relating to the application from Viridian NZ Bidco Limited seeking clearance to ...
Viridian is also advancing VRDN-003 as a potential best-in-class subcutaneous therapy for the treatment of TED, including two ongoing global phase 3 pivotal clinical trials, ...
Viridian Therapeutics (NASDAQ:VRDN) reported positive topline results from the THRIVE-2 phase 3 trial of veligrotug (VRDN-001) in chronic thyroid eye disease (‘TED’) patients.